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The standard membrane feeding assay (SMFA) is currently considered to be the ‘gold standard’ for assess-
ing the effectiveness of malaria transmission blocking interventions (TBIs) in vivo. The operation and
analysis of SMFAs has varied between laboratories: ﬁeld scientists often measure TBI efﬁcacy as a reduc-
tion in the prevalence of infected mosquitoes whilst laboratory scientists are more likely to quote efﬁcacy
as a change in the number of oocysts within the mosquito. These metrics give outputs that differ widely,
resulting in a need for greater understanding of how the SMFA informs TBI assessment. Using data from
536 different assays (conducted on Plasmodium falciparum and Plasmodium berghei, in either Anopheles
gambiae or Anopheles stephensi) it is shown that the relationship between these metrics is complex, yet
predictable. Results demonstrate that the distribution of oocysts between mosquitoes is highly aggre-
gated, making efﬁcacy estimates based on reductions in intensity highly uncertain. Analysis of 30 SMFAs
carried out on the same TBI conﬁrms that the observed reduction in prevalence depends upon the para-
site exposure (as measured by oocyst intensity in the control group), with assays which have lower expo-
sure appearing more effective. By contrast, if efﬁcacy is estimated as a reduction in oocyst intensity, then
this candidate demonstrated constant efﬁcacy, irrespective of the exposure level. To report transmission-
blockade efﬁcacy accurately, the results of SMFAs should give both the prevalence and intensity of
oocysts in both the control and intervention group. Candidates should be assessed against a range of par-
asite exposures to allow laboratory results to be extrapolated to different ﬁeld situations. Currently, many
studies assessing TBIs are underpowered and uncertainties in efﬁcacy estimates rarely reported. Statisti-
cal techniques that account for oocyst over-dispersion can reduce the number of mosquitoes that need to
be dissected and allow TBI candidates from different laboratories to be accurately compared.
 2012 Australian Society for Parasitology Inc. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.1. Introduction
The intolerable health and economic burdens imposed by
malaria have prompted an ambitious expansion of malaria control
activities, recently including local elimination and future eradica-
tion as key objectives (Alonso et al., 2011). A key component of this
endeavour is now recognised to be the interruption of transmission
of the parasites through the mosquito vector (Smith et al., 2011),
thereby reducing the number of secondary infections (Shaukat
et al., 2010). The efﬁcacy of newly developed transmission blocking
interventions (TBIs) needs to be accurately assessed; for example aInc. Published by Elsevier Ltd. Op
x: +44 207 402 3927.
T.S. Churcher).wide range of highly effective transmission blocking (TB) drugs and
vaccines have been developed in the laboratory and these candi-
dates now need to be selected and prioritised to transfer the best
of these new tools to the ﬁeld. This will require a standard method
by which to assess the effectiveness of TBIs that will allow results
from different laboratories to be compared directly.
The Standard Membrane Feeding Assay (SMFA) was developed
from an experimental laboratory protocol devised to study
transmission of malaria parasites to their vectors (Boyd, 1949;
Ponnudurai et al., 1987). The presence/number of oocysts is used
to report the success of infection, although it was quickly appreci-
ated that the production of oocysts did not necessarily correlate
with the successful transmission of the parasite from vector to ver-
tebrate host (Boyd, 1949). In the 1970–80’s the SMFA gained
acceptance as a useful and standard method to determine,en access under CC BY-NC-ND license. 
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tes, for which reporting oocyst production was the most direct
readout. The ability to make multiple identical replicates with or
without the intervention and to infect replicate groups of vectors
in vivo was key to this application, and the assay rapidly acquired
the accolade ‘gold standard’. In this assay, potential TBI candidates
are mixed with infectious gametocytes and fed to mosquitoes
which are then dissected after a ﬁxed time interval to determine
how efﬁciently oocysts have developed on the midgut. Although
this method is widely used across different laboratories, results
are reported in different and often conﬂicting formats. Studies
may report (i) the reduction in the proportion of infected mosqui-
toes (here deﬁned as oocyst prevalence, Medley et al., 1993) or (ii)
the reduction in the mean number of oocysts (here deﬁned as
oocyst intensity, see Medley et al., 1993). Experiments on TBIs have
focused on the changes in the numbers of parasites in a mosquito
as this is deemed the more discriminatory of the two metrics.
Despite these two metrics being clearly related (Billingsley et al.,
1994), the efﬁcacy of an intervention will be described differently
depending on which of the two measurements are used. This
uncertainty in presentation reﬂects the deeper lack of understand-
ing of how malaria transmission and the properties of mosquito
infection are measured. Field malariologists tend to report malaria
transmission as the Entomological Inoculation Rate (EIR), which is
the number of potentially infectious bites received per person per
time unit, in which a mosquito is deemed infectious if they have
salivary gland sporozoites, regardless of their number (Smith
et al., 2005). The apparent dichotomy between assay readouts
needs to be resolved if appropriate decisions about which potential
TBIs to take forward into ﬁeld trials are to be made.
To allow different TBI candidates to be compared fully in the
SMFA it is essential to understand the uncertainty around point
estimates, an issue that is rarely discussed in the scientiﬁc litera-
ture. Transmission ‘blockade’ is conventionally measured by the
change (fall or rise) in oocyst prevalence/intensity, induced by
the intervention, by comparison with an appropriate, control rep-
licate. The results are expressed as:
Efficacy ¼ C  E
C
 100 ð1Þ
where C is the mean prevalence/intensity in the control group and E
is the mean prevalence/intensity in the intervention group (Lensen
et al., 1999; Blagborough et al., 2012). The assay is repeated a num-
ber of times (typically three to ﬁve paired comparisons) and the
mean efﬁcacy reported. Results show here, that the accuracy of a re-
sult can vary dramatically depending on the number of mosquitoes
dissected in both the control and intervention groups, and the num-
ber of replicate feeds carried out.
Perhaps the biggest practical drawback of the SMFA is the cost
of the assay. Dissection of mosquito midguts and enumeration of
oocysts, particularly when working with human pathogens, im-
poses exceptionally high manpower, time and infrastructure costs.
Consequent ﬁnancial and/or practical pressures lead many to re-
duce the number of feeds and mosquitoes dissected to a ‘useful’
minimum. The number of feeds conducted and mosquitoes dis-
sected varies substantially between laboratories and power calcu-
lations are rarely determined, making comparison of different
candidates even within the same laboratory potentially imprecise.
An early critique of the assay used bootstrapping methodology to
examine factors that inﬂuenced the reproducibility of the method
and concluded that a study comparing oocyst intensity must have
a control group oocyst mean intensity of P35 (van der Kolk et al.,
2005). Although this might be desirable in some cases, in reality
oocyst counts in the control group are often signiﬁcantly lower
than this, and the results deemed to be less ‘valuable’. As a result,
more generalisable guidelines are required.Using data from 536 SMFA studies on both Plasmodium falcipa-
rum and Plasmodium berghei in Anopheles gambiae or Anopheles
stephensi, the underlying relationship between oocyst prevalence
and intensity is re-examined. It is shown how this relationship
explains why the same TBI candidate may give very different
estimates of TBI efﬁcacy under different experimental conditions,
discuss the consequent operational constraints of the SMFA, and
suggest an improved method of interpreting the data.2. Materials and methods
2.1. Parasites and mosquitoes
General parasite maintenance was carried out as described pre-
viously (Sinden, 2002; Blagborough et al., 2012). Plasmodium berg-
hei strains ANKA 2.34, PbGFPCON 259cl2 (Janse et al., 2006), or
PbGFPCON 507cl1, were maintained in 4–10 week old female
Tuck’s Ordinary (TO) or CD1mice (Harlan, UK) by serial mechanical
passage (up to a maximum of eight passages). Hyper-reticulocyto-
sis was induced 2–3 days before infection with 200 ll i.p. phen-
ylhydrazinium chloride (PH; 6 mg/ml in PBS; ProLabo, UK). Mice
were then infected i.p. with 108 P. berghei-infected mouse blood
cells and infections monitored with Giemsa-stained tail blood
smears (Sinden, 2002). Plasmodium falciparum strains 3D7 and
NF54 were maintained in asynchronous culture as described previ-
ously (Ifediba and Vanderberg, 1981; Graves et al., 1984). Anophe-
les stephensi mosquito strain SDA 500 and A. gambiae strains
N’Gousso and G3 were produced as described previously (Sinden,
2002), and maintained on fructose (8% (w/v) fructose, 0.05% (w/
v) p-aminobenzoic acid).2.2. The Standard Membrane Feeding Assay
2.2.1. Plasmodium berghei
Batches of Anopheles housed in pots at 19 C were starved for
24 h and then fed on heparinised P. berghei-infected blood using
standard membrane feeding methods (Sinden, 1996). Brieﬂy, in-
fected mice were exsanguinated into heparinised syringes. Hepa-
rinised blood was then added to tubes (at 37 C) containing the
antibody or drug under investigation with appropriate controls
(Normal/pre-immune serum with or without the drug (solvent
only)). These mixed preparations were offered through Paraﬁlm
membranes on feeders at 37 C to replicate pots of 50–200 female
mosquitoes obtained from the same generation/cohort. Twenty-
four hours after feeding, mosquitoes were brieﬂy anesthetised with
CO2 and unfed mosquitoes were removed. Mosquitoes were then
maintained at 19–22 C and 50–80% relative humidity. Recognising
that midgut oocyst numbers vary over time (Dawes et al., 2009b,)
midguts were dissected only on day 10 post-feeding. Mosquito
midguts were dissected and cohort size, infection prevalence and
the mean number of oocysts on the midgut (intensity), were mea-
sured for each pot of mosquitoes (Sinden, 1996; Blagborough et al.,
2012).2.2.2. Plasmodium falciparum
Mature gametocytes of P. falciparum (3D7 and NF54) were pro-
duced in vitro as described previously (Ifediba and Vanderberg,
1981; Graves et al., 1984). Brieﬂy, mature gametocyte cultures
(0.015–0.4% ﬁnal gametocytaemia) were fed for 30 min at 37 C
to mosquitoes through a Paraﬁlm membrane. Engorged mosqui-
toes were housed in pots at 28 C and 60–80% relative humidity.
On days 8–10, midguts were dissected and the results analysed
as in Section 2.2.1.
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Fig. 1. Results of 536 Standard Membrane Feeding Assays (SMFAs) used to assess
the effectiveness of 132 different transmission blocking intervention (TBI) candi-
date drugs and sera. Each point represents the efﬁcacy of a single paired experiment
as estimated using Eq. (1) (using the arithmetic mean). The colour of the point
represents the parasite species used, be it Plasmodium falciparum (blue) or
Plasmodium berghei (green) whilst the depth of the colour reﬂects the parasite
exposure (darker shading reﬂecting higher mean intensity in the control group).
The size of the point is relative to the number of mosquitoes dissected in each
paired experiment whilst the shape of the point denotes the species of vector used,
either Anopheles gambiae (square) or Anopheles stephensi (circle). Negative points on
either axis indicate estimates where the TBI candidate appeared to increase either
oocyst prevalence or intensity, although whether this is due to transmission
enhancement or measurement error associated with the assay cannot be deter-
mined. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
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A summary of the data used is given in Supplementary Table S1.
The number of oocysts in a mosquito is highly over-dispersed
(aggregated relative to the normal distribution) so here the statis-
tical analysis was carried out using data from individual dissected
mosquitoes (as opposed to mean oocyst estimates which is shown
to be highly uncertain at low sample sizes). Among the 536 exper-
iments analysed, individual mosquito count data were available for
189 different experimental feeds, in which a total of 9,119 mosqui-
toes were dissected (Supplementary Table S2). The relationship
between oocyst prevalence and intensity was estimated by extend-
ing the methods of Medley et al. (1993) which ﬁt a relationship
between the mean parasite intensity and parasite prevalence using
a binomial distribution. To fully capture the uncertainty in oocyst
estimates, a full negative binomial distribution is used to allow
the number of oocysts in infected mosquitoes to inﬂuence the dis-
tribution. To account for the abundance of uninfected mosquitoes
seen, a zero-inﬂated negative binomial distribution was also
tested. A range of different functional forms are used to describe
how k (an inverse measure of aggregation; see Eq. (1) of Medley
et al., 1993) changes with oocyst intensity. The most parsimonious
models were chosen using the likelihood ratio test.
Estimates of the number of mosquitoes that need to be dis-
sected (power calculations) were generated by sampling from the
best ﬁt distribution and functions according to the stated sample
size and using the results from Eq. (1) (with simulations run a
10,000 times to generate 95% conﬁdence intervals). Statistics were
further reﬁned using generalised linear mixed models (GLMMs),
with binomial error structure for prevalence data and zero-inﬂated
negative binomial for intensity data (Bolker et al., 2009). The
uncertainty around point estimates was calculated by bootstrap-
ping (for both mosquitoes and experimental feeds when estimates
involving multiple assays were required).3. Results
3.1. The relationship between oocyst prevalence and intensity
The results of 536 TBI assays on 132 different TBI candidates are
shown in Fig. 1. This graph suggests that interventions can have
widely different combinations of reported abilities to reduce oo-
cyst prevalence and intensity. Superﬁcial viewing might suggest
that for both P. falciparum and P. berghei a substantial reduction
in intensity (70%), may be required before a noticeable (10%)
impact upon prevalence is achieved. However, further analysis
suggests that this is not the case (see below).
The relationship between oocyst prevalence and intensity is
shown in Fig. 2A. For what is believed to be the ﬁrst time, these
data show that the same relationship holds in both the control
and the experimental groups. Fitting separate curves to the control
and experimental groups does not signiﬁcantly improve the ﬁt of
the model (likelihood ratio test P value = 0.060; see Supplementary
Fig. S1). This suggests that if an intervention reduces oocyst inten-
sity then the reduction seen in prevalence is entirely predicted by
the course of the black line plotted in Fig. 2A. The shape of the best
ﬁt relationship can then be used to show what reduction in preva-
lence is expected for a given reduction in intensity in experiments
in which the control intensity ranges from one to 100 oocysts
(Fig. 2B), i.e. in an individual SMFA assay, if the control group has
a mean oocyst intensity of 100 then one would only expect to
see a reduction in oocyst prevalence of 20% from a TBI which re-
duced oocyst intensity by 90% (Fig. 2B). Upon closer inspection of
Fig. 1 this can also be seen in the larger dataset of 536 paired
experiments. Darker points signifying higher oocyst densities inthe control group are more likely to be to the right of the x-axis,
showing the strongly non-linear relationship between blockade
of prevalence and blockade of intensity. The majority of data points
clearly suggest a highly non-linear relationship between the reduc-
tion in prevalence and the reduction in intensity. This will be exac-
erbated by the current assumption that high control oocyst
numbers equate to a ‘successful’ experiment within the majority
of laboratory studies (Fig. 2B).
Whilst recognising that the majority of the P. falciparum data
examined were gathered in different laboratories to the P. berghei
data, it is interesting to note that the prevalence-intensity relation-
ship appears relatively consistent between both parasite and vec-
tor combinations (Fig. 2A). Nevertheless statistical analysis shows
that ﬁtting different curves (Supplementary Fig. S2) to the different
parasite species separately signiﬁcantly improves the ﬁt of the
models (P < 0.001). Further analysis comparing data from P. falcipa-
rum and P. berghei from the same laboratory is needed to verify this
result, although for the purposes of this study a single curve ﬁtted
to the whole dataset is used as it will make relatively little practical
difference to power calculations. Laboratories may wish to im-
prove their power estimates by ﬁtting their own parasite-vector
combination-speciﬁc prevalence-intensity relationships.3.2. The aggregated distribution of oocysts
Medley et al. (1993) originally highlighted that the number of
oocysts in each mosquito is far from normally distributed. They
demonstrated that there are signiﬁcantly more uninfected mosqui-
toes for a given mean oocyst intensity than you would expect with
a Poisson (normal) distribution. This report goes further and
Fig. 2. The relationship between oocyst prevalence and intensity and how this relationship will determine the effectiveness of transmission blocking interventions (TBIs). (A)
Oocyst prevalence – intensity relationship estimated from 189 Standard Membrane Feeding Assays (SMFAs). The colour of the point represents the parasite species used:
Plasmodium falciparum (blue) or Plasmodium berghei (green). The dark shade denotes SMFA controls whilst the lighter shade signiﬁes experiments with candidate TBIs. The
size of the points indicates the number of mosquitoes dissected whist the shape denotes the species of vector used, either Anopheles gambiae (square) or Anopheles stephensi
(circle). Oocyst intensity is shown as the arithmetic mean. The black line indicates the best ﬁt model (see Supplementary Table S3 for the best ﬁt parameters). (B) The
expected relationships between efﬁcacy and oocyst prevalence and intensity when using different parasite exposures according to the model presented in (A). The colours of
the lines indicate the mean oocyst intensity in the control group, one (blue), ﬁve (green), 10 (orange), 50 (yellow) or 100 (red) oocysts. This can be compared with Fig. 1. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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toes and the number of uninfected mosquitoes observed. Results
indicate that the degree of oocyst aggregation (over-dispersion)
is even greater than previously described. Using a zero-inﬂated
negative binomial distribution (Log-likelihood: 21686) instead
of a normal negative binomial distribution (Log-likelihood:
21846; as used by Medley et al., 1993) signiﬁcantly improved
the ﬁt of the best-ﬁt model (P < 0.001). Across the whole dataset,
79% of oocysts were found in just 10% of all mosquitoes. The degree
of oocyst aggregation (as measured by the variance to mean ratio)
increases with increasing infection intensity (see Supplementary
Fig. S3). This aggregation can substantially increase the uncertainty
around study results, particularly in SMFAs with high parasite
exposure.3.3. Understanding the uncertainty around estimates generated using
the current method of analysis
3.3.1. Number of mosquitoes dissected
Parasite aggregation makes estimates of oocyst intensity highly
uncertain. This uncertainty is exacerbated when a relatively small
number of mosquitoes are dissected. This is illustrated in Fig. 3A
which is parameterised using the results of the model ﬁtted in
Fig. 2A and described in Supplementary Data S1. If only 20 mosqui-
toes were dissected, then a mean oocyst intensity of 20 would have
95% conﬁdence interval estimates that ranged from 10 to 50. A
worked interpretation and practical application of these ﬁndings is
described within Supplementary Data S2. Dividing one uncertain
result by another uncertain result (as done in Eq. 1) generates
highly uncertain estimates of TBI efﬁcacy. The uncertainty is worse
if there is a low intensity of oocysts in the control group (i.e. low
parasite exposure in the absence of a TBI), as small absolute
changes in the denominator can have a big effect on the overall
estimate of efﬁcacy. This is illustrated in Fig. 3B for an intervention
with a true efﬁcacy of 80%. If, as commonly practised, 20 mosqui-toes are dissected in both the control and the intervention group,
the 95% conﬁdence intervals for the efﬁcacy could range between
10% (enhancement) to 100% depending on the oocyst intensity
in the control group. Even if the control group had a mean oocyst
intensity of 50, the conﬁdence intervals would still be relatively
large (50% to 95%). To have relative conﬁdence in the precision
of the efﬁcacy estimates will require large numbers of mosquitoes
to be dissected (Fig. 3C). There is considerably more certainty in
the efﬁcacy estimates of highly effective interventions because
the degree of aggregation decreases with mean oocyst intensity.
This means that interventions with a lower efﬁcacy will typically
show greater variability in the efﬁcacy observed when using the
SMFA. Similar uncertain predictions were generated for efﬁcacy
estimates that rely on prevalence (Fig. 3D and E). The same prob-
lems arise when using Eq. (1), making SMFA results highly
uncertain.3.3.2. Number of experimental feeds
Decisions about potential TBIs are currently being made using
relatively small numbers of experimental replicates (often as low
as one). The results of 30 different paired assays using the same
TBI candidate (anti Pbs28 monoclonal antibody (mAb) 13.1) are
shown in Fig. 4A and B. There is considerable variation in assay
readout, between experimental feeds which could be explained
by heterogeneity between hosts (mice in this case), feeding appa-
ratus, experimental technique or cage effects. This uncertainty in
efﬁcacy should be taken into consideration when designing exper-
iments but also in the statistical analysis. Mosquitoes from the
same cage will not be statistically independent as they are more
likely to have similar levels of infection than mosquitoes fed and
reared for a replicate experiment. An example of this ‘‘cage effect’’
could be the degree with which the paraﬁlm is stretched over the
feeding device as that might inﬂuence mosquito infectivity for all
mosquitoes within that experimental feed, or the microbiota pres-
ent in the gut of mosquitoes reared in a single cohort. Studies
Fig. 3. Indications of the uncertainties in efﬁcacy estimates generated by 30 repeat Standard Membrane Feeding Assays (SMFAs) conducted on the same transmission
blocking intervention (TBI) candidate in the same laboratory using the standard method. Efﬁcacy is measured as either a reduction in the mean number of Plasmodium berghei
oocysts developing within Anopheles stephensi (A–C) or oocyst prevalence (D–F). (A) and (D) show the range of oocyst intensity estimates that could be observed for a given
true oocyst intensity according to the number of mosquitoes dissected, be it 10 (orange), 20 (yellow), 30 (green), 50 (light blue), 100 (dark blue), 200 (purple). (B) and (E)
show the range of efﬁcacies that could be generated by a TBI candidate with a true efﬁcacy of 80% (denoted by the black dashed line). Shaded colours represent different
sample sizes (as above). (C) and (F) show the minimum number of mosquitoes that need to be dissected to ensure that reported efﬁcacy is within 10% of the true efﬁcacy. If
the number of mosquitoes required is >500 then a value of 500 is given. All ﬁgures show 95% conﬁdence interval estimates. (For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 4. The range of efﬁcacies seen for a single transmission blocking intervention (TBI) candidate calculated using oocyst intensity (A) or prevalence (B). Each grey point
indicates a paired Plasmodium berghei – Anopheles stephensi assay with the size of the point representing the mean number of mosquitoes dissected in the experiment. Vertical
lines indicate 95% conﬁdence interval estimates. Black dotted lines show the average result pooling experiments of similar oocyst intensities in the control group together
(bin range, 0–50, 50–100, 100–150, 150–200, 200+). The large red point indicates the average efﬁcacy of the candidate (estimated using Eq. (1)) whilst the blue point shows
estimates derived using a mixed-effects model. (C) The minimum number of mosquitoes that need to be dissected to ensure that observed TBI efﬁcacy is within 10% of the
true efﬁcacy using the mixed-effects model. This method substantially reduces the number of mosquitoes that need to be dissected compared with the traditional method
(Fig. 3C). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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TBI efﬁcacies and, subsequently, differences between different TBI
candidates when they do not exist. Ideally multiple feeders and
cages should be used for each feed and it is suggested the results
be analysed using GLMMs. This multi-level analysis allows a single
estimate of the TBI efﬁcacy to be estimated (the ﬁxed effect) whilst
allowing the level of infection in the different assays (i.e. using dif-
ferent sources of blood, feeders or cages) to vary at random (the
random effect, see Bolker et al., 2009). GLMMs can allow the error
structure of the data to be described by a variety of different statis-
tical distributions. This is particularly appealing when dealing with
intensity data since it will reduce the variability associated with
the overdispersed data. These models also allow the overall esti-
mate to be weighted by the certainty in the individual feeding esti-
mates (determined by the number of mosquitoes dissected),
something which is ignored using the current standard method.
The advantages of using a GLMM as opposed to Eq. (1) are illus-
trated in Fig. 4C (in comparison with Fig. 3F). Using the GLMM esti-
mates of efﬁcacy are higher for both oocyst prevalence (64.0%
versus 56.5%) and intensity (91.5% versus 84.3%), and for the later
the 95% conﬁdence region is reduced by 43%.
ThedatainFig.4alsoillustrateshowtheefﬁcacyofaTBIcandidate,
calculated by reductions in oocyst prevalence, decreases the higher
theoocyst intensity inthecontrolgroup(Fig.4B). Interestingly, ifefﬁ-
cacy is estimated as changes in oocyst intensity then the candidate
has approximately the sameefﬁcacy irrespectiveof theoocyst inten-
sity in the control group (Fig. 4A) – this can be shown statistically by
including control oocyst intensity as a covariate in the GLMM;
reported efﬁcacy was signiﬁcantly lower in experiments with
control group intensities of >100 (Fig. 4B), where efﬁcacy was
reported by reduction in infection prevalence (P < 0.001) but not in
Fig. 4A, where efﬁcacywas reported by reduction in infection inten-
sity (P = 0.11).4. Discussion
Recognising the central importance of developing effective TBIs
to achieving the recently rediscovered objectives of local elimina-
tion and global eradication of malaria, and the established current
central role of the SMFA in evaluating such interventions, the tech-
nique has been re-analysed using a substantial body of data gath-
ered by this method on both model rodent (P. berghei) and human
malaria (P. falciparum). Results show that: (i) reductions in oocyst
prevalence and intensity follow predictable relationships, (ii) a sin-
gle TBI investigated in great detail (anti Pbs28 mAb 13.1) appears,
on average, to be equally effective irrespective of the number of
parasites ingested within the range tested, (iii) it is suggested that
previously published TBI efﬁcacy estimates are highly uncertain
due to aggregation of infections in mosquito cohorts and small
sample sizes, (iv) different statistical techniques should be used
to reﬁne efﬁcacy estimates and optimise power calculations, and
(v) it is strongly recommend that for every SMFA carried out
authors should report changes in oocyst prevalence and intensity
together with the mean control oocyst number and the number
of mosquitoes dissected. These points shall be discussed in turn
in relation to some of the technical questions challenging TBI
assessment.
Currently the efﬁcacy of transmission blocking vaccines (Carter,
2001), drugs (Delves et al., 2012) and other interventions
(Cirimotich et al., 2011) are most commonly estimated as a reduc-
tion in oocyst prevalence, oocyst intensity or both. Simply giving
point estimates of efﬁcacy fails to understand that these results,
and their associated uncertainty, will depend on the speciﬁc
variables of the experiment from which they were derived. Key
variables that are rarelymade explicit include the fact that blockadewas achieved at a particular intensity of exposure (as measured by
the mean oocyst number in the control group), and with an accu-
racy determined by the number of experimental infections and
the number of mosquitoes dissected in each experiment. This paper
has outlined how these variables have a substantial and predictable
impact upon the results reported.
It could be argued that the prevalence of mosquito infection is
more important in epidemiological terms than intensity. It is there-
fore tempting to estimate TBI efﬁcacy as a reduction in oocyst prev-
alence since detecting signiﬁcant changes in the number of
infected/uninfected is not complicated by highly infected mosqui-
toes. This method has the advantage in that it is quicker (a micros-
copist does not need to count oocysts, just detect their presence/
absence) and is easily mechanised using oocyst-speciﬁc markers
(e.g. P. berghei PbGFPCON 259cl2 (Vlachou et al., 2004), which pro-
duces ookinetes and oocysts expressing GFP in vivo). However,
using oocyst prevalence alone as a measure for efﬁcacy has a num-
ber of pitfalls. Firstly evidence indicates that the reduction in the
number of infected mosquitoes will depend on the parasite
exposure, with it being much easier to show reductions in oocyst
prevalence if there is a low or intermediate (<50%) oocyst preva-
lence in the control group. Secondly, in highly infected mosquitoes
small changes in oocyst prevalence can mask large differences in
oocyst intensity. This can be seen in Fig. 2A where increasing the
oocyst prevalence from 90% to 95% would increase oocyst intensity
by more than 2.6-fold (from a mean of 87–230). Ultimately, inves-
tigators will need all information to assess different TBI candidates
so that observed inhibition should be described for each pair of
assays, citing both oocyst intensity and prevalence, and the
experimental constraints of sample size and control oocyst number.
The clear relationship between oocyst prevalence and intensity,
and their respective reductions, will allow epidemiologists to pre-
dict how effective an intervention will be at reducing both the
number of infected bites and perhaps the number of parasites
within these bites. This will allow the results from laboratory as-
says to be extrapolated to the ﬁeld, allowing scientists who use dif-
ferent metrics (such as EIR) to communicate effectively. The most
effective reduction in the prevalence of oocysts will be when the
mean oocyst intensity in wild caught mosquitoes is at its lowest.
This is encouraging, recognising that oocyst counts from wild
caught mosquitoes are typically very low (Rosenberg, 2008), and
that in the majority of malaria-infected areas of the globe, the
EIR is reported to be less than one (Gething et al., 2010). Our ability
to predict what impact a TBI will have in the ﬁeld depends on
whether TBI candidates have approximately the same efﬁcacy at
reducing oocyst intensity, irrespective of intensity of infection in
the control group (Fig. 4A). In this study there were only sufﬁcient
repeat assays of a single intervention to do this statistical analysis
once; we would therefore strongly advise other candidates to be
tested in this thorough way (i.e. using gametocyte exposures that
generate a wide range of oocyst intensity/prevalence estimates in
the control group).
Over the years the SMFA has been reﬁned to maximise trans-
mission. This has been so successful that some laboratories can
repeatedly achieve levels of infection with very high oocyst densi-
ties, both in laboratory models (Farrance et al., 2011) and using
ﬁeld populations of human parasites (Harris et al., 2012). With
such high control oocyst intensities, and recognising the preva-
lence/intensity relationship described in Fig. 2, it is not surprising
that SMFAs have been used to estimate changes in oocyst intensity
in order to evaluate TBIs and understand the dynamics of the mos-
quito immune system. The ability of a TBI candidate to reduce oo-
cyst prevalence has been shown to depend on parasite exposure
(as measured by the number of oocysts in the control group,
Fig. 4B). As shown in Fig. 2B, just because an intervention fails to
achieve a sufﬁcient reduction in oocyst prevalence at high parasite
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tings. To fully evaluate the effectiveness of a TBI, mosquitoes
should be fed on hosts with a wide range of gametocyte densities
and not just those with the highest counts. This may involve feed-
ing mosquitoes on hosts with sub-microscopic gametocytemia
(Schneider et al., 2007).
There are a number of different reasons why the results of sep-
arate SMFAs might provide different readouts for a single interven-
tion. These can be broadly categorised as either ‘host’ effects (for
example differences in immunological responses) or due to intra-
laboratory experimental variation when performing the assay (dif-
ferent conditions in the cage or feeding apparatus). Both of these
sources of variability need to be embraced to enable different TBI
candidates to be compared accurately. Ideally, multiple experi-
mental replicates and mosquito populations should be used with
a number of different parasite preparations and the results ana-
lysed in a GLMM. This is potentially impractical to perform for each
individual assay. We suggest laboratories should estimate their
individual SMFA-variability once and use this information to adjust
the precision of subsequent feeding experiments. Our data sug-
gests that the number of oocysts in mosquitoes feeding on the
same blood sample is best described using a zero-inﬂated negative
binomial distribution. Using a statistical method (such as GLMMs)
that takes this distribution into account when analysing oocyst
intensity data will reduce the number of mosquitoes that need to
be dissected in order to achieve a statistically signiﬁcant result.
To carry out this type of statistical analysis requires individual oo-
cyst counts from all dissected mosquitoes, something that has
rarely been made available in the past once mean estimates have
been reported.
Swellengrebel (as reported in Boyd and Stratman-Thomas,
1933) advocated that ﬁeld studies examining malaria infections
in mosquitoes should examine a minimum of 100 mosquitoes,
and if at that point the estimate of mean oocyst intensity remains
variable, that the sample size be continuously expanded until sta-
ble values are reached. This commendable ideal is unfortunately
not a practical approach to the SMFA. The number of mosquitoes
that needs to be dissected will depend on the question under
investigation, the certainty with which the null hypothesis is re-
jected (the study’s power) and the type of statistical analysis that
will be carried out. It will also depend on the number of experi-
mental feeds to be carried out and the degree of intra-assay vari-
ability (as there is no beneﬁt in having highly precise estimates
from a single assay if there is considerable intra-assay variability).
This paper clearly illustrates that the number of mosquitoes to be
dissected will also depend on parasite exposure. Generally, the
higher the intensity in the control group, the fewer mosquitoes
that need to be dissected. Should the scientiﬁc community con-
tinue estimating efﬁcacy as reductions in oocyst intensity using
the standard method (Eq. 1), it must be acknowledged that a single
SMFA will require >100 mosquitoes to be dissected to ensure that
the recorded efﬁcacy is within 10% of the true efﬁcacy, if that efﬁ-
cacy is 80% or less (Fig. 3C). Fig. 3 can help inform this decision (a
worked example of this is given in Supplementary Data S2). Ulti-
mately no TBI efﬁcacy estimate should be given without an expres-
sion of the uncertainty around the point estimate. This can be
simply calculated using the GLMM or generated using bootstrap-
ping methodology using the traditional method (Eq. 1).
Perhaps the most frustrating aspect of this discussion is our
need to conclude the analysis at the point of oocyst burden. Sur-
prisingly, despite extensive studies (Boyd and Stratman-Thomas,
1933; Vaughan et al., 1992, 1999; Pumpuni et al., 1997; Beier,
1998; Frischknecht et al., 2004; Medica and Sinnis, 2005; Zollner
et al., 2006; Kebaier et al., 2009; Conteh et al., 2010) it is only in
P. berghei that the relationship between oocyst number and sali-
vary gland sporozoite burden has been described (Dawes et al.,2009a), and for no species is the relationship between the gross
salivary gland sporozoite load and the contribution of the mos-
quito to overall transmission known (the mosquito to human basic
reproduction number). This needs urgent resolution as without
this knowledge the impact that partially effective TBIs can have
on person-to-person transmission cannot easily be assessed.Acknowledgements
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